M. Leunig et al., EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR ON ANGIOGENESIS AND GROWTH OF ISOGRAFTED BONE - QUANTITATIVE IN-VITRO IN-VIVO ANALYSIS IN MICE, International journal of microcirculation, clinical and experimental, 17(1), 1997, pp. 1-9
Basic fibroblast growth factor (bFGF), a constituent of bone and carti
lage matrix, has been shown to be a potent mitogen for osteoblasts and
chondrocytes and yet an inhibitor of chondrocyte terminal differentia
tion in cell culture. To characterize the effect of bFGF on bone forma
tion, whole neonatal murine femora were cultured in the presence or ab
sence of bFGF and a neutralizing antibody against bFGF. In vitro, femo
ral elongation was provided by cartilage growth only; the calcified di
aphyseal zone stained by oxytetracycline did not increase. When bFGF w
as added to the culture medium, longitudinal growth of the proximal an
d distal cartilage was inhibited in a dose-dependent manner (p < 0.05)
, and the number of hypertrophic chondrocytes in the growth plate was
reduced. This phenomenon was absent in the presence of a neutralizing
antibody, which when given alone significantly promoted femoral elonga
tion. In contrast, in vivo after transplantation into adult mice beari
ng dorsal skin fold chambers, femora rapidly calcified after revascula
rization. This observation supports the notion that bone formation lar
gely depends on angiogenesis-mediated events. To verify this hypothesi
s, angiogenesis and bone formation were quantified using bFGF known to
be a stimulator of angiogenesis. Calcification of grafted femora was
accelerated by bFGF given intraperitoneally. The neutralizing antibody
slightly suppressed angiogenesis and femoral elongation (not statisti
cally significant), whereas intravenous injections of both substances
did not reveal a significant modulatory effect. In vivo the effect of
systemically administered bFGF was inhomogeneous, but there was a stro
ng correlation between angiogenesis and endochondral calcification (p
< 0.001). These results suggest that exogenous bFGF modulates bone for
mation in vitro by inhibition of terminal differentiation of chondrocy
tes in the growth plate, and angiogenesis and concomitant in vivo even
ts are pivotal in the promotion of rapid bone formation.